SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Study to look at Covid-19 impact on blood cancer patients
Fri May 22nd - A new UK study is to be launched that will examine how patients who receive stem cell transplants for blood cancers and blood disorders react to severe Covid-19 infection. More
'Focus on blood clotting in Covid-19 patients'
Fri May 22nd - There is an urgent need to focus on medications that address dangerous blood clotting in Covid-19 patients, according to a leading haematologist. More
Immunotherapy hope for elimination of leukaemia stem cells
Fri May 22nd - Hematopoietic stem cells can be selectively eliminated using immunotherapy instead of chemotherapy, a new Swiss study has revealed. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

Heart drugs 'safe' in Covid 19 patients

Wednesday April 1st, 2020

Researchers have examined the impact of common antihypertensive drugs on patients with Covid 19.

These drugs are often prescribed to people with conditions known to put patients at raised risk of severe Covid 19.

A team led by Dr Fabian Sanchis-Gomar of the University of Valencia, Spain, looked at the effect of the drugs angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.

Their findings appeared on Monday (30 March) in Mayo Clinic Proceedings.

The team explains that one of the ways the virus enters the body is through an enzyme in the lungs called ACE2, which converts angiotensin I to angiotensin II. This has led to concerns that these drugs, which also work on angiotensin, may increase the danger posed by Covid 19.

But after an in-depth review of more than 60 published studies, Dr Sanchis-Gomar and his team concludes that “no studies have reported an increase in circulating angiotensin-converting enzyme levels or expression thus far, and increased expression would not necessarily imply an increased risk of infection or disease severity."

Dr Sanchis-Gomar feels that: “In agreement with current guidelines, we recommend patients with hypertension should continue taking anti-hypertensive medications without interruption.”

Co-author Dr Carl Lavie adds: “Angiotensin II is known to foster inflammation, oxygenation, vasoconstriction, and fibrosis, so it is quite conceivable that a pharmaceutical agent that can inhibit the production of this hormone could actually be very beneficial for preventing lung injury and also for systemic health.

“Certainly, it is premature right now to start these agents as a preventive measure for Covid 19 in patients with no other indicator for Renin-angiotensin-aldosterone system inhibitors. However, this is an active area for investigation.”

Sanchis-Gomar, F. et al. Angiotensin-Converting Enzyme 2 and Anti-Hypertensives (Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors) in Coronavirus Disease 2019 (COVID-19). Mayo Clinic Proceedings 30 March 2020

Link to PDF: https://els-jbs-prod-cdn.jbs.elsevierhealth.com/

Tags: Europe | Flu & Viruses | Heart Health | Pharmaceuticals

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES